TheChineTime

Lilly-Backed China Startup Debuts With $68.7M Seed to Advance Next-Gen T Cell Engagers - BioSpace

2026-03-18 - 12:09

Lilly-Backed China Startup Debuts With $68.7M Seed to Advance Next-Gen T Cell Engagers BioSpace

Share this post: